Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...

Germany is widely recognized as one of the leading countries in the pharmaceutical industry boasting a rich history of innovation cutting-edge research and global influence With its well-established i ...

Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic ...

Bayer was founded in the year 1863 in Barmen in North Rhine Westphalia in the west of what was then the Kingdom of Prussia, today modern Germany. "What started as a small but innovative dyestuffs ...

Bayer is pressing ahead with a phase 3 trial ... stroke or stent thrombosis compared to placebo – both given alongside aspirin plus a P2Y12 inhibitor – at one year. Once again, there was ...

Ibuprofen Plus Triptan for Migraine Relief Ibuprofen Plus Antiemetic for Migraine Relief. For those who experience migraine ...

For decades, taking low-dose aspirin every day was widely recommended as an easy way to prevent heart attacks and strokes. But that advice has changed.

Investments in R&D and market expansion, particularly in emerging regions, will be crucial in shaping the future of the aspirin marketDublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Aspirin Global ...

People without the risk of heart problems who consumed daily low-dose aspirin, it increased the chance of bleeding in the ...

A Washington jury on Tuesday ordered Bayer to pay $100 million to four people who say they were sickened by toxic chemicals ...

Although Bayer’s top-selling drug Xarelto lost market exclusivity in most geographies in 2024, the company still predicts it will see strong growth from the pharma business unit beginning in 2027.